Paper37631985
BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1.
Jiang L and 8 others. Viruses, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1. Papers, record 37631985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37631985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Herpesvirus 1, Human | Major topic |
| Herpes Simplex | Major topic |
| Infant, Newborn | |
| Humans | |
| HeLa Cells | |
| Protein Kinase Inhibitors | |
| Antiviral Agents | |
| Cyclin-Dependent Kinases |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12135584 | Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. | Drug Resist Updat | 2002 | https://conductscience.org/library/papers/12135584 | PubMed |
| 2 | 14561402 | Cdk2 knockout mice are viable. | Curr Biol | 2003 | https://conductscience.org/library/papers/14561402 | PubMed |
| 3 | 9377190 | Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy. | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | 1997 | https://conductscience.org/library/papers/9377190 | PubMed |
| 4 | 12589832 | Herpes simplex virus resistance to antiviral drugs. | J Clin Virol | 2003 | https://conductscience.org/library/papers/12589832 | PubMed |
| 5 | 25036183 | Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity. | AIDS | 2014 | https://conductscience.org/library/papers/25036183 | PubMed |
| 6 | 20465793 | An overview of Cdk1-controlled targets and processes. | Cell Div | 2010 | https://conductscience.org/library/papers/20465793 | PubMed |
| 7 | 26542306 | Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/26542306 | PubMed |
| 8 | 14739611 | Apoptosis participates to liver damage in HSV-induced fulminant hepatitis. | Apoptosis | 2003 | https://conductscience.org/library/papers/14739611 | PubMed |
| 9 | 25003190 | CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. | J Clin Invest | 2014 | https://conductscience.org/library/papers/25003190 | PubMed |
| 10 | 9621021 | Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. | J Virol | 1998 | https://conductscience.org/library/papers/9621021 | PubMed |
| 11 | 15494896 | Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15494896 | PubMed |
| 12 | 11729253 | Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes. | J Am Soc Nephrol | 2001 | https://conductscience.org/library/papers/11729253 | PubMed |
| 13 | 23901090 | Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23901090 | PubMed |
| 14 | 31241436 | Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment. | Med Chem | 2020 | https://conductscience.org/library/papers/31241436 | PubMed |
| 15 | 34747367 | Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. | JCI Insight | 2021 | https://conductscience.org/library/papers/34747367 | PubMed |
| 16 | 21778105 | Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children. | J Clin Virol | 2011 | https://conductscience.org/library/papers/21778105 | PubMed |
| 17 | 30426158 | 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability. | Cancer Chemother Pharmacol | 2019 | https://conductscience.org/library/papers/30426158 | PubMed |
| 18 | 33618979 | Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics. | Trends Microbiol | 2021 | https://conductscience.org/library/papers/33618979 | PubMed |
| 19 | 9971799 | Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. | J Virol | 1999 | https://conductscience.org/library/papers/9971799 | PubMed |
| 20 | 23596085 | Recent developments in anti-herpesvirus drugs. | Br Med Bull | 2013 | https://conductscience.org/library/papers/23596085 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943421 | Proprietary Cationic Lipo-Oligopeptides Inhibit Herpes Simplex Virus-1 Infection. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943421 | PubMed |
| 42823736 | CDK7, CDK9, or CDK11 inhibition reduces neutrophil-driven inflammation and tissue damage in experimental autoimmune models. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42823736 | PubMed |
| 42075693 | CMGC Kinases in Viral Infection and Human Disease. | Pathogens | 2026 | https://conductscience.org/library/papers/42075693 | PubMed |
| 41827841 | Phosphoproteome Remodeling upon CDK1 Inhibition Restricts HSV-1 IE Gene Transcription and Replication. | Cells | 2026 | https://conductscience.org/library/papers/41827841 | PubMed |
| 41594640 | Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594640 | PubMed |
| 41575212 | A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention. | mBio | 2026 | https://conductscience.org/library/papers/41575212 | PubMed |
| 41327028 | Integrating of Machine Learning to Characterize Tumor-Infiltrating Immune Cell-Related Signature for Enhancing Prognosis for Glioma Patients. | Biol Proced Online | 2025 | https://conductscience.org/library/papers/41327028 | PubMed |
| 39931979 | Cyclin Dependent Kinases in Antiviral Drug Discovery. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39931979 | PubMed |
| 39466139 | The opportunities and challenges of epigenetic approaches to manage herpes simplex infections. | Expert Rev Anti Infect Ther | 2024 | https://conductscience.org/library/papers/39466139 | PubMed |
| 38616855 | Herpes simplex keratitis: A brief clinical overview. | World J Virol | 2024 | https://conductscience.org/library/papers/38616855 | PubMed |
| 38259968 | Anti-herpes simplex virus activities and mechanisms of marine derived compounds. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38259968 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37631985
GET https://conductscience.org/api/papers/v1/37631985/references?page=2